New Antibiotic Corbomycin For Antibiotic Resistant Bacteria
Scientists discovered a new antibiotic that attacks and kills bacteria through a unique approach.
The newly developed antibiotic ‘corbomycin’ is a promising candidate to tackle the emerging issue of antibiotic resistance in pathogens.
Antibiotic resistance is one of the biggest threats to global health, according to the World Health Organization. 700,000 deaths happen every year around the world due to growing antibiotic resistance in microbes.
The new antibiotic, along with a less popular complestatin, blocks the function of bacterial wall, eventually killing them. This is the first time scientists are observing such a phenomenon.
The cell wall that surrounds the cell giving them shape, is the source of bacteria’s strength.
Usually, antibiotics like penicillin prevent the bacteria from building this wall. But the new antibiotic they discovered does just the opposite, prevents cell wall from breaking down.
Breaking of the cell wall is crucial for the bacteria cells to grow, divide, and expand. The bacteria get trapped if the cell wall can’t be broken as they can’t divide and grow. Complestatin and the new antibiotic corbomycin belong to the same family of antibiotics produced by soil bacteria called glycopeptides
Staphylococcus aureus infection that can lead to toxic shock syndrome and blood poisoning can be blocked in mice using these new antibiotics.